FDA Approves Unknown Drug — RISING

# FDA Approves Rising's Generic Drug Application The FDA approved ANDA200542 for Rising Pharmaceuticals on April 28, 2017, expanding the company's generic drug portfolio and positioning it to capture additional market share in the competitive generic pharmaceutical sector. The approval enables Rising to bring a new therapeutic option to market at a potentially lower cost, offering patients and payers greater access to affordable medications.